MANAGEMENT OF RETINAL PIGMENT EPITHELIUM TEAR DURING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.

"The Vision Academy is an educational initiative that is fully funded by Bayer. Financial arrangements of the authors with companies whose products may be related to the present report are listed below, as declared by the authors. P. Mitchell: Consultant for Bayer and Novartis. F. J. Rodríguez: Lecture fees from NIDEK and Topcon; advisory board fees from Kodiak; advisory board lecture fees from Novartis, Bayer, and Allergan. A. M. Joussen: Consultant for Bayer, Novartis, Allergan, Boehringer Ingelheim, and Omeicos; grant support from Novartis and Bayer. A. Koh: Consultant for Bayer. N. Eter: Consultant for Bayer, Novartis, and Roche; research grants from Bayer and Novartis; lecture fees from Bayer, Novartis, and Allergan. D. T. Wong: Personal fees and non-financial support from Bayer during the conduct of the study; personal fees from AbbVie, personal fees from Alcon, other from Artic DX, grants, personal fees, and non-financial support from Novartis, grants from Roche, non-financial support from Topcon, personal fees from Zeiss, and personal fees from Bausch Health, outside the submitted work. J.-F. Korobelnik: Consultant for Bayer, Thea, Zeiss, Allergan, Roche, KangHong, and Novartis. A. A. Okada: Non-financial support from Bayer Healthcare AG during the conduct of the study; personal fees from Bayer Healthcare AG, grants and personal fees from Bayer Yakuhin Ltd. (Japan), grants and personal fees from Novartis Pharma KK (Japan), grants and personal fees from Santen Pharmaceutical Co, Ltd, grants and personal fees from Mitsubishi Tanabe Pharma Corporation, personal fees from AbbVie Japan, Inc, personal fees from Astellas Japan, personal fees from Senju Pharmaceutical Co, Ltd, personal fees from Daiichi-Sankyo, outside the submitted work. The concepts for this article were originally discussed at a meeting convened by Bayer that discussed topics for physician education on eye disorders, for which participants, including the authors on this publication, received an honorarium. The authors received no payment in relation to the development of this publication, which was developed separately from the meeting."

"Editorial assistance for the writing and revision of the draft manuscript was provided by Laura George, PhD, and Rob Kite, BSc(Hons), of Complete HealthVizion, Ltd., on the basis of detailed discussion and feedback from all the authors; this assistance was funded by Bayer Consumer Care AG, Pharmaceuticals, Basel, Switzerland. The Vision Academy is an educational initiative that is fully funded by Bayer. Financial arrangements of the authors with companies whose products may be related to the present report are listed below, as declared by the authors."